Tricyclic diazepines of the Formula I: ##STR1## wherein A, B, D, E, F, Y, and Z are defined in the specification which compounds have vasopressin and oxytocin antagonist activity.
(4-Substituted-phenyl)-(5H-10,11-dihydro-pyrrolo [2,1-c][1,4] benzodiazepin-10-yl)-methanone derivatives as vasopressin receptor modulators
作者:Aranapakam M. Venkatesan、George T. Grosu、Amedeo A. Failli、Peter S. Chan、Joseph Coupet、Trina Saunders、Hussain Mazandarani、Xun Ru
DOI:10.1016/j.bmcl.2005.08.007
日期:2005.11
Synthesis and structure-activity relationships (SAR) of arginine vasopressin (AVP) receptor modulators are described. Potent and selective compounds are prepared when the amide linkage connecting rings A and B of VPA-985 is replaced with a bond, C=O, -O-, -S-, or -SO2- bond. (c) 2005 Elsevier Ltd. All rights reserved.
TRICYCLIC VASOPRESSIN ANTAGONISTS
申请人:American Cyanamid Company
公开号:EP0805813B1
公开(公告)日:2002-05-15
PYRROLOBENZODIAZEPINE PYRIDINE CARBOXAMIDES AND DERIVATIVES AS FOLLICLE-STIMULATING HORMONE RECEPTOR ANTAGONISTS